Please email us at [email protected] with our item No, NDC#, UPC# or the product link if you have any quetions. We are located in Oceanside, California. Search over 110,000 items by Name, Item No., NDC, UPC (without dashes) or by Mfg.Name. Please note, Prescription items can only be ordered by a Drug Manufacturer, Wholesaler, Hospital, Governmental Medical Facility, VA, Pharmacy, Physician, Physician Assistant, Nurse Practitioner, Dentist, Podiatrist, Optometrist, Veterinarian, Naturopath, Licensed Lab, Physical Therapist & Pharmacist in their scope of practice. No order will ship, unless you you have provided us the Medical License (and DEA Lic. in case of controlled drug) and we had verified that. Rx items can only be shipped to AZ, AR, CA, CT, DE, FL, GA, GU, HI, IL, KS, KY, LA, ME, MA, MI, NJ, NY, PA, PR, TX, TN, VA, WA, WI and WV. If you are an International Physician or Pharmacist, please contact us before ordering.


Menu

Rx Item-Carbidopa-Levodopa-Entacapone 50/200/200 Tab 100 By Sandoz Gen Stalevo

Item No.: RX339008 NDC No.781566901 00781-5669-01 0781566901 00781566901 UPC No.:307815669010 307815-669010bNDC No. 00781-5669-01 UPC/GTIN No. 3-07815-66901-0 MPN No. 566901Item No.: RX339008 NDC No.781566901 00781-5669-01 0781566901 00781566901 UPC No.:307815669010 307815-669010bNDC No. 00781-5669-01 UPC/GTIN No. 3-07815-66901-0 MPN No. 566901Only Lic.-Physician,Pharmacy,Dentist,Drug Mfg,Dist.,Gov,Hospital,Lic.Lab,Naturalist,Naturopath,NP,Optometrist,Pharmacist,PA,Physical Therapist,Podiatrist,Research Co.,Uni.,VA,Vet & Wholesalers in scopWant to do Research on this Med or need a large quantity? Email Details with quantity required to:sales@AmericanPharmaWholesale.comVisit AmericanPharmaWholesale.com for over 100,000 items of Health & Beauty at Retail@Wholesale prices.Item No.: RX339008 NDC No.781566901 UPC No.:307815669010 NDC No. 00781-5669-01 UPC/GTIN No. 3-07815-66901-0 MPN No. 566901 Only Lic.-Physician, Pharmacy, Dentist, Drug Mfg, Dist., Gov, Hospital, Lic.LBRAND: CARBIDOPA-LEVODOPA-ENTACAPONE NDC: 00781-5669-01,781566901 UPC: 3-07815-66901-0,307815669010

Rx Item-Carbidopa-Levodopa-Entacapone 50/200/200 Tab 100 By Sandoz Gen Stalevo

$375.08$99.99

Item No.: RX339008 NDC No.781566901 00781-5669-01 0781566901 00781566901 UPC No.:307815669010 307815-669010bNDC No. 00781-5669-01 UPC/GTIN No. 3-07815-66901-0 MPN No. 566901 Only Lic.-Physician, Pharmacy, Dentist, Drug Mfg, Dist., Gov, Hospital, Lic.Lab, Naturalist, Naturopath, NP, Optometrist, Pharmacist, PA, Physical Therapist, Podiatrist, Research Co., Uni., VA, Vet & Wholesalers In Scope Of their Practice Can Order RX Item. RX Item No. RX339008 Carbidopa-Levodopa-Entacapone 50/200/200 Tab 10

Have a question?

Clinical Information:Generic Code And Description: 63191 Carbidopa/Levodopa/Entacapone Oral Tablet 50-200-200 Strength: 50 Mg-200 Mg-200 MgDose Form: Tablet Product Category: Rx Pharmaceuticals Fine Line Class: 850085008510 All Rx Products DEA Class: None Omp Family:Drug Class: 28361600 Dopamine Precursors28361200 Catechol-O-Methyltransferase(Comt)Inhib.Active Ingredients: 1085 Carbidopa 388214971639 Levodopa 599277684 Entacapone 130929576 Inactive Ingredients: 2272 Mannitol 696582598 Sucrose 57501 These highlights do not include all the information needed to use CARBIDOPA, LEVODOPA AND ENTACAPONE safely and effectively. See full prescribing information for CARBIDOPA, LEVODOPA AND ENTACAPONE. CARBIDOPA, LEVODOPA AND ENTACAPONE tablets, for oral use Initial U.S. Approval: 2003 INDICATIONS AND USAGE Carbidopa, levodopa and entacapone tablets, a combination drug consisting of levodopa (aromatic amino acid), carbidopa (aromatic amino acid decarboxylation inhibitor), and entacapone (catechol-O-methyltransferase (COMT) inhibitor) are indicated for the treatment of Parkinson's disease. Carbidopa, levodopa and entacapone tablets are to be used: • To substitute (with equivalent strengths of each of the three components) for carbidopa/levodopa and entacapone previously administered as individual products (1) • To replace carbidopa/levodopa therapy (without entacapone) when patients experience the signs and symptoms of end-of-dose “wearing-off” and when they have been taking a total daily dose of levodopa of 600 mg or less and have not been experiencing dyskinesias (1) DOSAGE AND ADMINISTRATION • The optimum daily dosage of carbidopa, levodopa and entacapone tablets must be determined by careful titration in each patient (2.1) • Individual tablets should not be split or fractionated. Administer only one tablet at each dosing interval (2.6) DOSAGE FORMS AND STRENGTHS Each carbidopa, levodopa and entacapone tablet contains a 1:4 ratio of carbidopa to levodopa and 200 mg of entacapone (mg of carbidopa per mg of levodopa per mg of entacapone) (3) • Carbidopa, levodopa and entacapone tablets 12.5 mg per 50 mg per 200 mg • Carbidopa, levodopa and entacapone tablets 18.75 mg per 75 mg per 200 mg • Carbidopa, levodopa and entacapone tablets 25 mg per 100 mg per 200 mg • Carbidopa, levodopa and entacapone tablets 31.25 mg per 125 mg per 200 mg • Carbidopa, levodopa and entacapone tablets 37.5 mg per 150 mg per 200 mg • Carbidopa, levodopa and entacapone tablets 50 mg per 200 mg per 200 mg CONTRAINDICATIONS • Concomitant use of nonselective monoamine oxidase (MAO) inhibitors (4) • Narrow-angle glaucoma (4) WARNINGS AND PRECAUTIONS • May cause falling asleep during activities of daily living without apparent warning, and daytime drowsiness and somnolence (5.1) • May cause syncope and hypotension/orthostatic hypotension (5.2) • May cause or exacerbate dyskinesia (5.3) • May cause depression and suicidality (5.4) • May cause hallucinations and/or other psychotic-like behavior (5.5) • May cause problems with impulse control and compulsive behaviors (5.6) • Abrupt discontinuation may cause hyperpyrexia and confusion (5.7) • May cause diarrhea and/or drug-induced colitis (5.8) • May cause rhabdomyolysis (5.9) • Increased risk of melanoma (5.10) ADVERSE REACTIONS The most common adverse reactions (incidence 3% or higher than placebo incidence) are dyskinesias, urine discoloration, diarrhea, nausea, abdominal pain, vomiting, and dry mouth (6) To report SUSPECTED ADVERSE REACTIONS, contact Sandoz Inc. at 1-800-525-8747 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. DRUG INTERACTIONS • Drugs metabolized by COMT: use with caution (5.11,7.2) • Anti-hypertensive agents: dose adjustment may be required (7.3) • Tricyclic antidepressants: risk of hypertension and dyskinesia reported during concomitant use with carbidopa/levodopa (7.4) • Dopamine D2 receptor antagonists, isoniazid, phenytoin, papaverine and iron salts: may reduce efficacy of carbidopa, levodopa and entacapone tablets (7.5, 7.6, 7.7, 7.8, 7.9) • Drugs that interfere with biliary excretion, glucuronidation and intestinal beta-glucuronidase: dose adjustment of carbidopa, levodopa and entacapone tablets may be required (7.10) • Drugs metabolized by CYP2C9 (e.g., coumadin): dose adjustment of carbidopa, levodopa and entacapone tablets may be required; monitor INR when initiating carbidopa, levodopa and entacapone tablets in patients on coumadin (7.11) USE IN SPECIFIC POPULATIONS • Pregnancy: based on animal data, may cause fetal harm (8.1) See 17 for PATIENT COUNSELING INFORMATION. Revised: 2/2016

Item No.: RX339008 NDC No.781566901 00781-5669-01 0781566901 00781566901 UPC No.:307815669010 307815-669010bNDC No. 00781-5669-01 UPC/GTIN No. 3-07815-66901-0 MPN No. 566901
Carbidopa-Levodopa-Entacapone
Item No.: RX339008 NDC No.781566901 00781-5669-01 0781566901 00781566901 UPC No.:307815669010 307815-669010bNDC No. 00781-5669-01 UPC/GTIN No. 3-07815-66901-0 MPN No. 566901

Item No.: RX339008 NDC No.781566901 00781-5669-01 0781566901 00781566901 UPC No.:307815669010 307815-669010bNDC No. 00781-5669-01 UPC/GTIN No. 3-07815-66901-0 MPN No. 566901
Carbidopa-Levodopa-Entacapone
Item No.: RX339008 NDC No.781566901 00781-5669-01 0781566901 00781566901 UPC No.:307815669010 307815-669010bNDC No. 00781-5669-01 UPC/GTIN No. 3-07815-66901-0 MPN No. 566901

Only Lic.-Physician,Pharmacy,Dentist,Drug Mfg,Dist.,Gov,Hospital,Lic.Lab,Naturalist,Naturopath,NP,Optometrist,Pharmacist,PA,Physical Therapist,Podiatrist,Research Co.,Uni.,VA,Vet & Wholesalers in scop
Click above for Stalevo
Only Lic.-Physician,Pharmacy,Dentist,Drug Mfg,Dist.,Gov,Hospital,Lic.Lab,Naturalist,Naturopath,NP,Optometrist,Pharmacist,PA,Physical Therapist,Podiatrist,Research Co.,Uni.,VA,Vet & Wholesalers in scop

Want to do Research on this Med or need a large quantity? Email Details with quantity required to:sales@AmericanPharmaWholesale.com
Buy More Save More!
Want to do Research on this Med or need a large quantity? Email Details with quantity required to:[email protected]

Visit AmericanPharmaWholesale.com for over 100,000 items of Health & Beauty at Retail@Wholesale prices.
AmericanPharmaWholesale.com
Visit AmericanPharmaWholesale.com for over 100,000 items of Health & Beauty at Retail@Wholesale prices.

Item No.: RX339008 NDC No.781566901 UPC No.:307815669010 NDC No. 00781-5669-01 UPC/GTIN No. 3-07815-66901-0 MPN No. 566901 Only Lic.-Physician, Pharmacy, Dentist, Drug Mfg, Dist., Gov, Hospital, Lic.L
Rx Item-Carbidopa-Levodopa-Entacapone 50
Item No.: RX339008 NDC No.781566901 UPC No.:307815669010 NDC No. 00781-5669-01 UPC/GTIN No. 3-07815-66901-0 MPN No. 566901 Only Lic.-Physician, Pharmacy, Dentist, Drug Mfg, Dist., Gov, Hospital, Lic.L

BRAND: CARBIDOPA-LEVODOPA-ENTACAPONE NDC: 00781-5669-01,781566901 UPC: 3-07815-66901-0,307815669010
Sandoz/Rx
BRAND: CARBIDOPA-LEVODOPA-ENTACAPONE NDC: 00781-5669-01,781566901 UPC: 3-07815-66901-0,307815669010